Single dose of Pfizer or Astra Zeneca COVID-19 vaccine offers substantial protection to
older adults in long-term care facilities, but does not completely eliminate transmission
2021-06-24
(Press-News.org) A new study to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) (9-12 July) and published this week in The Lancet Infectious Diseases shows that, for residents of long-term care homes for adults aged 65 years and over, a single dose of either the Pfizer or Astra Zeneca COVID-19 vaccine offers around 60% protection against infection from SARS-CoV-2. The study is by Dr Madhumita Shrotri and Dr Laura Shallcross, UCL Institute of Health Informatics, University College London, UK, and colleagues.
The greatest effects of SARS-CoV-2 have been in residents of long-term care facilities, who represent a small fraction of the general population but account for a disproportionate number of SARS-CoV-2-related deaths in many countries, including the UK. As in other countries, the UK prioritised residents of these care homes to receive the first doses of COVID-19 vaccines that arrived in the country.
To obtain real-world data on the effectiveness of these vaccines (Pfizer and Astra Zeneca) in care homes, the authors used data from the VIVALDI study, an ongoing study since June 2020 to investigate SARS-CoV-2 transmission, infection outcomes, and immunity in residents and staff in long-term care facilities in England that provide residential or nursing care for adults aged 65 years and older.
This analysis included long-term care facility residents undergoing routine asymptomatic SARS-CoV-2 testing between Dec 8, 2020 (the date the first vaccine was administered in the study cohort), and March 15, 2021, using national testing data linked within the COVID-19 Datastore. This study was completed before the emergence of the Delta variant of SARS-CoV-2 now dominating in the UK.
The researchers estimated the reduced risk of PCR-positive infection at 0-6 days, 7-13 days, 14-20 days, 21-27 days, 28-34 days, 35-48 days, and 49 days and beyond after vaccination, compared with unvaccinated residents, adjusting for age, sex, previous infection, local SARS-CoV-2 incidence, long-term care facility bed capacity, and clustering by long-term care facility.
The analysis included 10412 care home residents aged 65 years and older from 310 facilities, with a median age of 86 years, of whom 70% were female and 1155 residents (11%) had evidence of previous SARS-CoV-2 infection. A total of 9160 (88%) residents received at least one vaccine dose during the study period, of whom 6138 (67%) received Astra Zeneca (ChAdOx1) and 3022 (33%) received Pfizer (BNT162b2).
Between Dec 8, 2020, and March 15, 2021, there were 36352 PCR tests carried out, with 1335 PCR-positive infections detected (713 in unvaccinated residents and 612 in vaccinated residents). The risk of infection was 56% lower in vaccinated residents after 28 to 34 days, days, and 62% lower at 35-48 days. Similar effect sizes at 35-48 days were seen for the Astra Zeneca vaccine (68% reduced risk of infection) and the Pfizer vaccine (65% reduced risk).
The authors say: "Single-dose vaccination with either the Astra Zeneca or the Pfizer COVID-19 vaccine reduces the risk of SARS-CoV-2 in older residents in long-term care facilities. Our findings suggest that vaccination also has an effect on SARS-CoV-2 transmissibility by reducing the total number of infections in residents, as well as their infectivity. The protective effect of a single dose of vaccination is evident from 4 weeks to at least 7 weeks after vaccination, which provides some evidence to support extension of the interval between doses beyond 3 weeks, in line with UK policy. However, even beyond 4 weeks, a single vaccine dose does not eliminate infection risk, highlighting the continued importance of non-pharmaceutical measures to control transmission within long-term care facilities."
They add: "Further work is required to evaluate the effectiveness of the second dose of the vaccine, and the effect of vaccination on transmission. This knowledge will be critical to inform policy decisions regarding revaccination schedules in this vulnerable population and the disease control measures needed in the short, medium, and long term to protect long-term care facilities from future waves of SARS-CoV-2 infection."
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-24
A new study by Dana-Farber Cancer Institute researchers has given scientists their first look at the genomic landscape of tumors that have grown resistant to drugs targeting the abnormal KRASG12C protein. Their work shows that, far from adopting a common route to becoming resistant, the cells take a strikingly diverse set of avenues, often several at a time.
The findings, reported online today in the END ...
2021-06-24
A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help it spread also makes it vulnerable to a new class of drug candidates, a new study finds.
Led by researchers at NYU Grossman School of Medicine, a research team showed that coronavirus reproduction in infected human cells requires chemical changes made by the human protein METTL3 to RNA, a key form of genetic material. Additional human proteins involved in the recognition of modified RNA, YTHDF1 and YTHDF3, were also found to be important to the process.
Published online in Genes and Development on June 24, the study showed for the first time that ...
2021-06-23
Hospitalizations to treat pediatric gun injuries are expensive, and U.S. taxpayers and the poor are bearing the price, according to a new study from the Stanford University School of Medicine.
The study, which published online June 23 in PLOS ONE, found that the average cost of an initial hospitalization for a pediatric firearm injury is around $13,000. A total of about $109 million is spent on such hospitalizations in the country each year. The figures do not capture the total costs of rehabilitating young gunshot victims, which can be much higher.
Research into the financial, health and social costs of firearm injuries in the United States has focused mostly on adults, said the study's senior author, Stephanie Chao, ...
2021-06-23
In a groundbreaking study, a team of UC Davis researchers has discovered a special type of stem cell that can reduce the amount of the virus causing AIDS, boosting the body's antiviral immunity and repairing and restoring the gut's lymphoid follicles damaged by the simian immunodeficiency virus (SIV), the equivalent of the human immunodeficiency virus (HIV) in non-human primates. ...
2021-06-23
Adult corals that survive high-intensity environmental stresses, such as bleaching events, can produce offspring that are better suited to survive in new environments. These results from a series of experiments conducted at the Bermuda Institute of Ocean Sciences (BIOS) in 2017 and 2018 are deepening scientists' understanding of how the gradual increase of sea surface temperatures and other environmental disturbances may influence future coral generations.
Researchers on the project included BIOS marine ecologists Samantha de Putron and Gretchen Goodbody-Gringley (now with the Central Caribbean Marine Institute), ecophysiologist Hollie Putnam at the University of Rhode Island (URI), and Kevin Wong, then ...
2021-06-23
WACO, Texas (June 23, 2021) - When an organization supports its employees who choose to adopt children, the employees, their families, the adopted children and the organization itself experience positive benefits and outcomes, according to new research from Baylor University.
The study, "It Takes a Village: How Organizational Support for Adoption Positively Affects Employees and Their Families," is published in the Journal of Occupational and Organizational Psychology. Researchers from Baylor's Hankamer School of Business include Matthew J. Quade, Ph.D., associate professor of management; ...
2021-06-23
FOR IMMEDIATE RELEASE
STUDY SUGGESTS THAT SMOOTHER SILICONE BREAST IMPLANTS REDUCE SEVERITY OF IMMUNE SYSTEM REACTIONS
According to researchers at Johns Hopkins Medicine, the Massachusetts Institute of Technology (MIT) and Rice University in Houston, silicone breast implants with a smoother surface design have less risk of producing inflammation and other immune system reactions than those with more roughly textured coatings. Results of the experiments using mice, rabbits and samples of human breast tissue advance knowledge of how the body responds to such implants, providing new information to physicians and affirming ...
2021-06-23
PHILADELPHIA - Researchers have been investigating the potential health-promoting qualities of extra virgin olive oil (EVOO) for decades, including its possible medicinal value for preventing cancer, Alzheimer's, and cardiovascular disease, as part of the well-known Mediterranean diet. However, consumers in the U.S. have been slow to embrace it as a staple in their diet. This reluctance, say scientists, might be in part due to EVOO's bitter taste and pungency, which is caused by the presence of substances known as phenolic compounds, the very ones believed to contribute to EVOO health benefits. In 2005, researchers from the Monell Chemical ...
2021-06-23
Microscopy is an essential tool in many fields of science and medicine. However, many groups have limited access to this technology due to its cost and fragility. Now, researchers from the Universities of Göttingen and Münster have succeeded in building a high-resolution microscope using nothing more than children's plastic building bricks and affordable parts from a mobile phone. They then went on to show that children aged 9-13 had significantly increased understanding of microscopy after constructing and working with the LEGO® microscope. Their results were published in The Biophysicist.
The researchers designed ...
2021-06-23
New York, NY--June 23, 2021--A challenging frontier in science and engineering is controlling matter outside of thermodynamic equilibrium to build material systems with capabilities that rival those of living organisms. Research on active colloids aims to create micro- and nanoscale "particles" that swim through viscous fluids like primitive microorganisms. When these self-propelled particles come together, they can organize and move like schools of fish to perform robotic functions, such as navigating complex environments and delivering "cargo" to targeted locations.
A Columbia Engineering team led by Kyle Bishop, professor of chemical engineering, is at the forefront of studying and designing the dynamics of active colloids powered by chemical reactions ...
LAST 30 PRESS RELEASES:
[Press-News.org] Single dose of Pfizer or Astra Zeneca COVID-19 vaccine offers substantial protection to
older adults in long-term care facilities, but does not completely eliminate transmission
